Portal hemodynamic effects of lenvatinib in patients with advanced hepatocellular carcinoma: A prospective cohort study
Hisashi Hidaka(Kitasato University), Wasaburo Koizumi(Kitasato University), Kosuke Kubota(Kitasato University), Xue Shao(Second Affiliated Hospital of Jilin University), Shigehiro Kokubu, Takahide Nakazawa(Kitasato University Hospital), Akitaka Shibuya, Shuichiro Iwasaki(Kitasato University), Naohisa Wada(Kitasato University), Yuhsaku Kanoh(Kitasato University), Yusuke Hara(Kitasato University), Haruki Uojima(National Center for Global Health and Medicine), Yoshiaki Tanaka(Jichi Medical University)
Cited by 31
Related Papers
Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells.
|Journal of Biological Chemistry|1990|1.5k
KN-62, 1-[N,O-bis(5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenylpiperazi ne, a specific inhibitor of Ca2+/calmodulin-dependent protein kinase II.
|Journal of Biological Chemistry|1990|625
N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide, a calmodulin antagonist, inhibits cell proliferation.
|Proceedings of the National Academy of Sciences|1981|586
Selective inhibition of catalytic activity of smooth muscle myosin light chain kinase.
|Journal of Biological Chemistry|1987|513
MAPKAP kinase‐2; a novel protein kinase activated by mitogen‐activated protein kinase.
|The EMBO Journal|1992|481